Clinical Trials Logo
  1. Home
  2. Cancer-Related Fatigue
  3. NCT02846389
  4. Details
NCT02846389 Clinical Trial

Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer

Cancer Related Fatigue Clinical Trial

Official title:
Randomized Controlled Trial of Exercise to Reduce Cancer Related Fatigue in Women Undergoing Radiation Treatment for Breast Cancer

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT02846389
Other study ID # Pro2016-0162
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 21, 2016
Est. completion date May 2026

Study information
Verified date September 2022
Source Hackensack Meridian Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Like other cancer treatments, radiation therapy can make people feel fatigued, or tired. The investigators think that moderate exercise, done 15 minutes at a time, can reduce the fatigue. This study is designed to gather more information, so that in the future, doctors can recommend whether patients should engage in exercise during a radiation treatment course.

Description:

Cancer related fatigue (CRF) is a common and debilitating side effect of radiotherapy in breast cancer patients. Physical activity interventions can attenuate CRF. The proposed study is a randomized, controlled trial (RCT) of exercise of structured moderate-intensity exercise intervention, delivered concurrently with radiotherapy, to reduce CRF and improve health-related quality of life among breast cancer patients. Eighty women with breast cancer scheduled to receive radiation therapy at Hackensack University Medical Center (HUMC) will be randomized to one of the two trial arms:1) a facility-based aerobic exercise utilizing a portable stationary pedal exerciser; or 2) a control group. Intervention arm participants will exercise at the hospital either before or after their radiation treatment. Assessments will be conducted at baseline, 4 weeks into radiation course, and at 4-week follow-up visit. The outcome variables are CRF, biomarkers of inflammation, and health-related quality of life (QOL). The study will provide preliminary evidence on whether a short-term moderate-intensity exercise intervention might be effective in reducing CRF in women undergoing radiotherapy for breast cancer, and whether this effect is mediated by inflammation.

Read more »

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Moderate Exercise
Aerobic training utilizing the portable stationary pedal exerciser (Pedlar) which contains two cycling pedals mounted to a stationary block that allows patients to exercise while sitting. Participants are required to perform 15 minutes/day of aerobic exercise using the Pedlar device on radiation treatment days; during a standard radiation course, this will typically yield 75 minutes/week of aerobic time.

Locations
Country Name City State
United States Hackensack University Medical Center Hackensack New Jersey

Sponsors (2)
Lead Sponsor Collaborator
Hackensack Meridian Health Lombardi Comprehensive Cancer Center

Country where clinical trial is conducted

United States, 

References & Publications (34)

See more »

Outcome
Type Measure Description Time frame Safety issue
Primary Assessment of change in fatigue via Functional Assessment of Chronic Illness Therapy (FACIT-Fatigue) survey instrument. The FACIT is a 13-item subscale developed to identify a finite set of concerns specific to fatigue. The responses to the 13 items on the FACIT-Fatigue questionnaire are each measured on a 4-point likert scale, with score ranging from 0 to 52. The FACIT-Fatigue scale has been validated in patients with cancer and showed excellent internal consistency and reliability. Baseline, 4 weeks into RT, 4 week follow up visit
Primary Assessment of change in blood biomarker of inflammation: High sensitivity CRP (hsCRP) Serum hsCRP will be measured on the Vitros 5,1 FS Chemistry platform via an immunoassay with a reportable range of 0.10 -15.00 mg/L, and intra- and inter-assay CVs of 1.8-4.0%. Baseline, 4 weeks into RT, 4 week follow up visit
Primary Assessment of change in blood biomarker of inflammation: Serum fibrinogen Fibrinogen will be measured using standardized clinical protocols. All assays have intra- and inter-assays coefficient of variations <10%. Baseline, 4 weeks into RT, 4 week follow up visit
Primary Assessment of change in blood biomarker of inflammation: Ferritin Ferritin will be measured using standardized clinical protocols. All assays have intra- and inter-assays coefficient of variations <10%. Baseline, 4 weeks into RT, 4 week follow up visit
Primary Complete blood count data (CBC) We will collect CBC data at each blood draw for correlative and explorative purposes. Baseline, 4 weeks into RT, 4 week follow up visit
Secondary Assessment of change in Cancer-related healthcare quality of life (HRQOL) measured using the Functional Assessment of Cancer Therapy (FACT) system questionnaires. The HRQOL measures four different domains (physical well-being, functional well-being, emotional well-being, and social/family well-being). FACT-B is a breast cancer specific module that will be used to reflect patients' concerns; moreover, they are reliable, reproducible, and have been validated in numerous studies. Baseline, 4 weeks into RT, 4 week follow up visit
See also
  Status Clinical Trial Phase
Completed NCT01564394 - Body Mind Training Project N/A
Recruiting NCT03730298 - American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients N/A
Completed NCT01926678 - Efficacy of Swedish Massage Therapy on Cancer-related Fatigue in Cancer Survivors Phase 2
Active, not recruiting NCT06120595 - REBECCA-2 Study: Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data N/A
Recruiting NCT06435091 - REBECCA-3 Study, Research on Breast Cancer Induced Chronic Conditions Supported by Causal Analysis of Multi-source Data
Terminated NCT01990066 - Home Based Exercise Program for Elderly Cancer Patients N/A
Not yet recruiting NCT04235946 - Feasibility Study of an Adapted and Supported Water Polo Program to Reduce Fatigue Related to Cancer and Improve Psychological and Social Recovery in Patients With Breast Cancer Remission N/A
Not yet recruiting NCT01881516 - Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF） Phase 2
Recruiting NCT03773003 - Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME) N/A
Not yet recruiting NCT05696275 - Using Combine Walking and Elastic Band to Decrease Fatigue N/A
Completed NCT01440621 - Modafinil in Cancer Related Fatigue Phase 3
Recruiting NCT02127268 - Thymosin-α1 in Cancer-Related Fatigue Phase 3